announced the agency approved their i-Factor Peptide Enhance Bone Graft for use in anterior cervical discectomy and fusion (ACDF) procedures in patients with degenerative disc disease. But on November 3, 2015, Cerapedics, Inc. Contact us at content (at) ilfkp (dot) com Translation and Foreign language trainings Specialists in translations and delivering medium size to large turn key. Integrating KUBRA, the industry leader in digital and traditional billing and payment solutions, with newly acquired iFactor, the market leader in outage communications, repositions the company as a complete customer experience management solution provider with core competencies in meter-to-cash and outage communications. It's been a long, long time since the FDA gave their PMA (Premarket Approval) application blessing to bone graft for the spine. i-FACTOR Peptide Enhanced Bone Graft is the only. FT Accountant (2224), 40, Infrastructure Factor Consulting (Ifactor) FT Software Sales Representative (2211), 53, Infrastructure Factor Consulting (Ifactor). Today, KUBRA announces changes to the company’s overall product offering. Cerapedics is an ortho-biologics company focused on developing and commercializing its proprietary small peptide (P-15) technology platform.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |